Across TCGA pan-cancer cohorts, CFAP99 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CFAP99 data layer compared with 27 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher CFAP99 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP99 expression acts as an unfavorable survival marker.

SCLC are the cancer types where CFAP99 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	DFS	Median	II,III,IV	0.137	0.562	.013	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CFAP99 tumor-vs-normal RNA expression · all CFAP99 data types